Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Jan Aushadhi Hindered By Hurdles
The Government was supposed to launch a policy for the ‘Jan Aushadhi Scheme’ in September 15. However, it has been delayed due to…
Roadmap for sustainable growth
Dr Ajit Dangi, President and Chief Executive Officer, Danssen Consulting, outlines measures needed to ensure the Indian pharma…
Shaping the growth agenda
Dr RB Smarta, Managing Director, Interlink, talks about the changing scenario in the pharma sector , the growth trends and the…
Is it time for ‘One Pharma’?
Dr Gopakumar G Nair, Chief Executive Officer, Gopakumar Nair Associates, elaborates about the scope for coming together as ‘One…
In search of an effective health system
Ranjana Smetacek, Director General, Organisation of Pharmaceutical Producers of India speaks about the need for innovation in…
Ensuring sustainable development
Dr Arun Garg, General Secretary – IPGA, Prof & Dean, School of Medical & Allied Sciences, KR Mangalam University, Gurgaon…
Why UCPMP needs to be statutory
Dr Milind Antani, Legal and Tax Counseling Worldwide & Anay Shukla, Member, Pharma and Life Science team, Nishith Desai…
IPM clocks Rs 8601 crores in October 2015
Eight therapies have outgrown the IPM growth
Cipla ready to launch low-dose Efavirenz 400 mg
Studies found that the reduced dose of 400 mg Efavirenz was non-inferior to the standard dose of 600 mg Efavirenz dose
Experts address impact of M&A in pharma
Also, deliberate on promoting API manufacturing in pharma